MDMustafa Demirpençe

Mustafa Demirpençe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mustafa Demirpençe has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Tiroid Nodüllerine Klinik Yaklaşım

    by Mustafa Demirpençe

    Tiroid nodülü, tiroid bezi içinde yapısal değişiklik sonucu oluşan ve çevresinden yapı ve içerik olarak farklı yapıda olan yuvarlak veya oval oluşumlardır. Büyük bir çoğunluğu benign karakterde olup ve asemptomatiktir. Nodül saptanması durumunda tiroid stimulan hormon (TSH) ölçümü yapılması gerekmektedir. Eğer TSH değeri düşük saptanırsa serbest T3 ve T4 ölçülmelidir. TSH değeri yüksekse serbest T4 ölçülüp santral hipotiroidi dışlanınca, kronik tiroidit tanısı açısından antitiroid peroksidaz antikoru (anti-TPO) ölçülmelidir. Anti-tiroglobulin antikoru ise anti-TPO normal olanlarda ölçülmelidir. Tiroglobulin ölçmenin yararı yoktur. Kalsitonin düzeyinin rutin olarak ölçülmesi hala tartışmalıdır. Ultrasonografik olarak değerlendirilip kriterleri uygun olan nodüllere ince iğne aspirasyon biyopsisi yapılması gerekmektedir.

  • Tiroid Kanserlerine Güncel Yaklaşım

    by Emine Bihter Eniseler, Zübeyde Yıldırım, Bartu Çetin, Mustafa Demirpençe, Seda Baştürk, Selda Yılmaz Tatar, Mehmet Alper Yılmaz, Emir Gökhan Kahraman, Gürkan Gül, Kıvanç Mercan, et al.

    Tiroid Kanserlerinde Epidemiyoloji Emine Bihter ENİSELER Tiroid Kanserlerinde Patoloji Zübeyde YILDIRIM Tiroid Kanserlerinde Radyolojik Tanı Yontemleri Bartu ÇETİN Tiroid Nodullerine Klinik Yaklaşım Mustafa DEMİRPENCE Tiroid Kanserlerinde Cerrahi Seda BAŞTÜRK Diferansiye Tiroid Karsinomlarında Radyoaktif İyot Tedavisi Selda YILMAZ TATAR Tiroid Kanserlerine Genel Bakış Mehmet Alper YILMAZ Papiller Tiroid Kanseri Emir Gökhan KAHRAMAN Folikuler Tiroid Kanseri Emir Gökhan KAHRAMAN Tiroid Onkositik Karsinomu Gürkan GÜL Meduller Tiroid Kanseri Gürkan GÜL Anaplastik Tiroid Kanseri Kıvanç MERCAN Herediter Non-Meduller Tiroid Kanserleri Kıvanç MERCAN Tiroid Kanserlerinde Radyoterapi Endikasyonları Fatma SERT Tiroid Kanserlerinde İzlem Selda YILMAZ TATAR

  • Open Access

    Galanin-like peptide and its correlation with androgen levels in patients with polycystic ovary syndrome

    by Mustafa Demirpence, Hamiyet Yilmaz Yasar, Inanc Karakoyun, Elif Merve Girgin

    Introduction: We aimed to investigate serum galanin-like peptide (GALP) levels and their correlation with hormonal and metabolic parameters in patients with polycystic ovary syndrome (PCOS). Material and methods: The study included 48 women (age range, 18–44 years) with a diagnosis of PCOS, and a control group that included 40 healthy females (age range, 18–46 years). Waist circumference, body mass index (BMI), and Ferriman-Gallwey score were evaluated and plasma glucose, lipid profile, oestradiol, progesterone, total testosterone, prolactin, insulin, dehydroepiandrosterone sulphate (DHEA-S), follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), 25-hydroxyvitamin D (25(OH)D), fibrinogen, d-dimer, C-reactive protein (CRP), and GALP levels were measured in all study subjects. Results: Waist circumference (p = 0.044) and Ferriman-Gallwey score (p = 0.002) were significantly higher in patients with PCOS compared to the control group. Among the metabolic and hormonal parameters studied, only total testosterone was significantly higher in patients with PCOS (p = 0.002). Also, the serum 25(OH)D level was significantly lower in the PCOS group (p = 0.001). CRP, fibrinogen, and D-dimer levels were all similar between the 2 groups. Serum GALP level was significantly higher in PCOS patients (p = 0.001). GALP was negatively correlated with 25(OH)D (r = –0.401, p = 0.002) and positively correlated with total testosterone values (r = 0.265, p = 0.024). Multiple regression analysis revealed that both total testosterone and 25(OH)D significantly contributed to GALP levels. Conclusions: Our study is the first in the literature to evaluate serum GALP levels in patients with PCOS. Increased GALP levels in PCOS and its association with total testosterone levels might show that GALP can act as an intermediary in increased GnRH-mediated LH release, which is one of the underlying pathogenetic mechanism of PCOS. Introduction: We aimed to investigate serum galanin-like peptide (GALP) levels and their correlation with hormonal and metabolic parameters in patients with polycystic ovary syndrome (PCOS). Material and methods: The study included 48 women (age range, 18–44 years) with a diagnosis of PCOS, and a control group that included 40 healthy females (age range, 18–46 years). Waist circumference, body mass index (BMI), and Ferriman-Gallwey score were evaluated and plasma glucose, lipid profile, oestradiol, progesterone, total testosterone, prolactin, insulin, dehydroepiandrosterone sulphate (DHEA-S), follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroid-stimulating hormone (TSH), 25-hydroxyvitamin D (25(OH)D), fibrinogen, d-dimer, C-reactive protein (CRP), and GALP levels were measured in all study subjects. Results: Waist circumference (p = 0.044) and Ferriman-Gallwey score (p = 0.002) were significantly higher in patients with PCOS compared to the control group. Among the metabolic and hormonal parameters studied, only total testosterone was significantly higher in patients with PCOS (p = 0.002). Also, the serum 25(OH)D level was significantly lower in the PCOS group (p = 0.001). CRP, fibrinogen, and D-dimer levels were all similar between the 2 groups. Serum GALP level was significantly higher in PCOS patients (p = 0.001). GALP was negatively correlated with 25(OH)D (r = –0.401, p = 0.002) and positively correlated with total testosterone values (r = 0.265, p = 0.024). Multiple regression analysis revealed that both total testosterone and 25(OH)D significantly contributed to GALP levels. Conclusions: Our study is the first in the literature to evaluate serum GALP levels in patients with PCOS. Increased GALP levels in PCOS and its association with total testosterone levels might show that GALP can act as an intermediary in increased GnRH-mediated LH release, which is one of the underlying pathogenetic mechanism of PCOS.


  • Open Access

    Are patients with obesity “scapegoats”? The obesity prejudice levels of health care workers in Turkey

    by Hülya Parildar, Ozge Ucman Tuncer, Mustafa Kursat Sahin, Mustafa Demirpençe, Hamiyet Yilmaz

    OBJECTIVE: This study assessed obesity prejudice levels, attitudes, and perceptions of health care workers toward individuals with obesity and the relationship between health care workers' perceptions of own and society's weight bias, healthy lifestyle preferences, body mass index, and other factors with obesity prejudice levels. METHODS: This cross-sectional and descriptive study was conducted with 700 health care workers in Turkey via an online survey addressing characteristics, perceptions, and attitudes toward obesity including an obesity prejudice scale. Categorical variables were expressed as frequencies and percentages. The chi(2) test was applied to compare categorical variables. The distribution of the data was evaluated by the Kolmogorov-Smirnov test. Normally distributed data were compared by an independent sample t-test, while the Mann-Whitney U and Kruskal-Wallis tests were used for comparing non-normally distributed data. RESULTS: Participants' mean age was 40.2 +/- 11.3 years and 67.9% were women. Notably, 57.9% worked at tertiary health care centers, 85.9% were physicians, and 64.8% were family physicians; 25% were prejudicial, while 58.1% tended to have prejudice toward individuals with obesity. Obesity prejudice scores were significantly higher among those who were in close contact with and who stated their preference for patients with obesity. CONCLUSIONS: Half of the participants tended to have prejudice, and one-fourth were prejudicial toward individuals with obesity. These results highlight the necessity of raising awareness of health care workers to reduce prejudicial attitudes that may negatively impact patients with obesity. Stigmatizing experiences might be detrimental, reducing the quality of life with long-term consequences for emotional and physical health.


  • The Evaluation of Thrombospondin 1 Levels in Patients with Acromegaly

    by Mustafa Demirpençe, Hamiyet Yılmaz, Ayfer Çolak, Merve Zeytinli, Demet İnce, Barış Önder Pamuk

  • Open Access

    Apelin: A potential novel serum biomarker for early detection of diabetic nephropathy in patients with type 2 diabetes

    by Mustafa Demirpençe

    OBJECTIVE: Diabetic nephropathy (DN) is the major cause of chronic renal failure, and proteinuria is an independent risk factor for the end stage renal disease. The random urine protein: creatinine ratio (P: C ratio) can accurately predict the amount of 24-hour urinary protein excretion. Apelin is thought to be associated with endothelial dysfunction, angiogenesis, and inflammation. This study investigated the apelin concentration and its association with the urine P: C ratio, and metabolic parameters in subjects with and without type 2 diabetes mellitus (T2D). METHODS: This study involved 86 subjects: 56 with newly diagnosed and untreated T2D and 30 non-diabetic controls. All subjects underwent a complete clinical examination that included anthropometric and laboratory measurements. RESULTS: Twenty-four males and sixty-two females participated in this study, and their mean age was 52.27 +/- 11.34 years. There were no differences in age, thyrotropin-stimulating hormone (TSH), creatinine clearance, and apelin levels between groups. As expected, fasting plasma glucose, weight, body mass index, and HbA1C were higher in T2D subjects (p=0.001, p=0.02, p=0.03, and p=0.001, respectively). Although apelin levels were higher in the control group, the differences were not statistically significant (p=0.93). The P: C ratio levels were lower in the control group, and the differences were statistically significant (p=0.006). A Spearman correlation analysis revealed that serum apelin levels were not correlated with the urine P: C ratio. CONCLUSION: Our study demonstrates that T2D is associated with decreased serum apelin levels and increased urine P: C ratios compared to those in non-diabetic subjects. This association may depend on impaired glucose homeostasis. Our results show that the serum apelin levels were not correlated with the urine protein: creatinine ratio and provide further evidence regarding the relationship between apelin and DN.


  • Open Access

    Wpływ gastrektomii rękawkowej na poziom irisiny w surowicy pacjentów z chorobliwą otyłością

    by Mustafa Demirpence, Hamiyet Yilmaz, Ayfer Colak, Hulya Yalcin, Burak Toprak, Hakan Turkon, Levent Ugurlu, Cengiz Aydin

    Irisin, a recently identified myokine, is associated with increased energy expenditure and has a potential role in obesity. Therefore, we investigated circulating irisin levels in morbidly obese patients undergoing sleeve gastrectomy (SG). Thirty morbidly obese patients undergoing SG and 30 healthy subjects were included. All participants were evaluated at baseline and again at three months post-SG. Body weight and height, the lipid profile, and plasma glucose, HbA1c, insulin, and irisin levels were measured at each visit. The two groups had similar mean age and sex distribution. Serum irisin was significantly lower in the morbidly obese subjects compared with the controls (p = 0.003) and negatively correlated with BMI, body weight, insulin levels, and HOMA-IR (p = 0.006, p = 0.011, p = 0.046, p = 0.048, respectively). When the morbidly obese patients were re-evaluated three months post-SG, their weight and BMI had significantly decreased (both p = 0.001). Similarly, the insulin, HbA1c, HDL-cholesterol, and HOMA-IR values significantly decreased (p = 0.001, p = 0.028, p = 0.006, and p = 0.001, respectively). However, irisin levels remained unchanged (p = 0,267). Although the irisin levels were significantly lower in the morbidly obese subjects, they did not change after SG-induced weight loss. (Endokrynol Pol 2016; 67 (5): 481-486).